Americans will receive vaccine record cards and text message reminders to keep track of their COVID-19 vaccine. Here's what else you need to know.
The CDC reduced its quarantine recommendation for those exposed to COVID-19 who are not showing symptoms. Here's what you need to know.
As the U.K. approves the Pfizer vaccine, the Centers for Disease Control and Prevention has released more details on who will have first access in the U.S.
The CDC may shorten its quarantine guidelines for those who believe they were exposed to COVID-19, according to a report in the Wall Street Journal. Experts are endorsing the change.
An ER doctor and nurse share the major challenges they're facing on the frontlines — and why it's "maddening" that some Americans still doubt the virus is real.
With over 1 million new cases of COVID-19 in the last week alone, doctors and nurses say the health care system is overwhelmed.
The Food and Drug Administration issued the first emergency use authorization for at at-home COVID-19 rapid test Wednesday. Here's what you need to know.
Claims that melatonin can treat or prevent COVID-19 are misguided, experts say, citing flaws in a Cleveland Clinic study that explored the concept.
Experts say Pfizer's COVID-19 vaccine poses logistical challenges that "no company in the world has ever faced." Here's why Moderna's may have a better chance at widespread distribution.
U.S. drugmaker Moderna announced Monday that its vaccine candidate was nearly 95 percent effective in early trials. Here's why that may be good news for other candidates.
With more than 160,000 new coronavirus cases on Thursday alone, the U.S. has officially reached what experts call exponential spread. Here’s why the “explosive” number of cases is so dangerous.
The CDC confirmed this week that a mask protects not only those around you but also you. Learn which ones the organization recommends.
American drugmaker Pfizer announced Monday that its COVID-19 vaccine has proven 90 percent effective in phase III clinical trials, which experts say may lead to approval by late November.
A new study suggests that COVID long-haulers may experience skin symptoms for months. One describes them to Yahoo Life as "like bugs were crawling all over my skin."
While trick-or-treating and other Halloween traditions can be altered to mitigate risks, experts tell Yahoo Life that things like bobbing for apples should be retired. "That's like kissing, once removed," says Vanderbilt University's Dr. William Schaffner.
El Paso County, Texas, has issued a curfew in response to a surge in cases. Experts weigh in on how this protective measure compares with others.
The Food and Drug Administration has approved remdesivir as a treatment for hospitalized COVID-19 patients. Here's what you need to know.
Epidemiologists weigh in on the safety precautions ahead of tonight's presidential debate in Nashville.
“Every time there's a group of people together, it could be a superspreader event,” says William Schaffner, an infectious disease expert at Vanderbilt University.
A new CDC report found that race and age are two of the highest risk factors associated with dying of COVID-19. Dr. Uché Blackstock says it's proof that "living in a country with racism ages people."
A new study suggests that people with Type O blood are less likely to get COVID-19 and less likely to get severely ill if they do contract it. Here's why Type A and AB may be putting some at higher risk.